Skip to content
October 29, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
The Dual-Coverage Challenge: Analyzing the Financial and Clinical Realities of Medicare-Medicaid Enrollees the-dual-coverage-challenge-analyzing-the-financial-and-clinical-realities-of-medicare-medicaid-enrollees
  • Breast Cancer Legislation and Policy

The Dual-Coverage Challenge: Analyzing the Financial and Clinical Realities of Medicare-Medicaid Enrollees

Nana Muazin July 26, 2026
Introduction: The Complexity of Dual Eligibility In the intricate landscape of the American healthcare system, approximately 12...
Read More Read more about The Dual-Coverage Challenge: Analyzing the Financial and Clinical Realities of Medicare-Medicaid Enrollees
AI and Human Collaboration: The Future of Breast Cancer Screening, New Research Suggests ai-and-human-collaboration-the-future-of-breast-cancer-screening-new-research-suggests
  • Medical Research and Clinical Trials

AI and Human Collaboration: The Future of Breast Cancer Screening, New Research Suggests

Dwi Wanna July 26, 2026
URBANA-CHAMPAIGN, IL – The most effective way to leverage the transformative power of artificial intelligence in the...
Read More Read more about AI and Human Collaboration: The Future of Breast Cancer Screening, New Research Suggests
A Global Lifeline at Risk: Bridging the Divide in Blood Safety and Availability a-global-lifeline-at-risk-bridging-the-divide-in-blood-safety-and-availability
  • Breast Cancer Prevention and Lifestyle

A Global Lifeline at Risk: Bridging the Divide in Blood Safety and Availability

Siti Muinah July 26, 2026
The World Health Organization (WHO) has released its Global status report on blood safety and availability 2025,...
Read More Read more about A Global Lifeline at Risk: Bridging the Divide in Blood Safety and Availability
The Dawn of De-escalation: DAPHNe Trial Signals a Paradigm Shift in HER2-Positive Breast Cancer Care the-dawn-of-de-escalation-daphne-trial-signals-a-paradigm-shift-in-her2-positive-breast-cancer-care
  • Patient Advocacy and Support

The Dawn of De-escalation: DAPHNe Trial Signals a Paradigm Shift in HER2-Positive Breast Cancer Care

Lina Hope July 26, 2026
Introduction: A New Era in Precision Oncology For decades, the prevailing philosophy in oncology was "more is...
Read More Read more about The Dawn of De-escalation: DAPHNe Trial Signals a Paradigm Shift in HER2-Positive Breast Cancer Care
Bioinformatics: Navigating the Frontier of Modern Healthcare with Fern Kirkham bioinformatics-navigating-the-frontier-of-modern-healthcare-with-fern-kirkham
  • Genomics and Precision Medicine

Bioinformatics: Navigating the Frontier of Modern Healthcare with Fern Kirkham

Rifan Muazin July 26, 2026
In the rapidly evolving landscape of modern medicine, few disciplines have witnessed as dramatic an expansion as...
Read More Read more about Bioinformatics: Navigating the Frontier of Modern Healthcare with Fern Kirkham
Operation Trialblazer: A Bold Bid to Revitalize US Early-Stage Clinical Research Amidst Global Competition operation-trialblazer-a-bold-bid-to-revitalize-us-early-stage-clinical-research-amidst-global-competition
  • Medical Research and Clinical Trials

Operation Trialblazer: A Bold Bid to Revitalize US Early-Stage Clinical Research Amidst Global Competition

Nana Wu July 26, 2026
Washington D.C. – The U.S. Department of Health and Human Services (HHS) has launched "Operation Trialblazer," a...
Read More Read more about Operation Trialblazer: A Bold Bid to Revitalize US Early-Stage Clinical Research Amidst Global Competition
Beyond Potency: Merck’s Strategic Evolution with Calderasib and the Tumor-Agnostic Paradigm beyond-potency-mercks-strategic-evolution-with-calderasib-and-the-tumor-agnostic-paradigm
  • Chemotherapy and Targeted Therapy

Beyond Potency: Merck’s Strategic Evolution with Calderasib and the Tumor-Agnostic Paradigm

Evan Lee Salim July 26, 2026
For decades, the KRAS gene—a master regulator of cellular growth—was considered the "holy grail" of oncology, yet...
Read More Read more about Beyond Potency: Merck’s Strategic Evolution with Calderasib and the Tumor-Agnostic Paradigm
A Symphony of Resilience: The Intergenerational Bond Between Daralt and Libby a-symphony-of-resilience-the-intergenerational-bond-between-daralt-and-libby
  • Integrative Oncology and Holistic Care

A Symphony of Resilience: The Intergenerational Bond Between Daralt and Libby

Muslim July 26, 2026
In the landscape of San Francisco’s storied LGBTQ+ history, few organizations have served as a more consistent...
Read More Read more about A Symphony of Resilience: The Intergenerational Bond Between Daralt and Libby
Bonds of Blood and Battle: The Parallel Cancer Journeys of Samantha and Tori bonds-of-blood-and-battle-the-parallel-cancer-journeys-of-samantha-and-tori
  • Patient Advocacy and Support

Bonds of Blood and Battle: The Parallel Cancer Journeys of Samantha and Tori

Nana July 26, 2026
By [Your Name/Agency] Published: November 05, 2025 In the complex landscape of modern oncology, the narrative of...
Read More Read more about Bonds of Blood and Battle: The Parallel Cancer Journeys of Samantha and Tori
The Hidden Vulnerability: An In-Depth Look at America’s Dual-Eligible Population the-hidden-vulnerability-an-in-depth-look-at-americas-dual-eligible-population
  • Breast Cancer Legislation and Policy

The Hidden Vulnerability: An In-Depth Look at America’s Dual-Eligible Population

Raul Delapena Setiawan July 25, 2026
For the tens of millions of Americans relying on public health insurance, the intersection of Medicare and...
Read More Read more about The Hidden Vulnerability: An In-Depth Look at America’s Dual-Eligible Population

Posts pagination

Previous 1 … 472 473 474 475 476 477 478 … 835 Next

Recent Posts

  • Unmasking the Silent Threat: Groundbreaking St. Jude Research Reveals Genetic Blueprint of Secondary Cancers in Childhood Survivors
  • Eli Lilly’s Retatrutide Surges Ahead in Weight Loss Race, Outperforming Novo Nordisk’s Ozempic in Landmark Trial
  • Reclaiming Intimacy: Navigating Sexual Health After Breast Cancer Treatment
  • Breakthroughs in Breast Cancer: Key Insights from the ESMO Annual Congress
  • Strengthening the Global Health Architecture: A Deep Dive into the WHO-Netherlands Strategic Dialogue

Recent Comments

No comments to show.

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

unmasking-the-silent-threat-groundbreaking-st-jude-research-reveals-genetic-blueprint-of-secondary-cancers-in-childhood-survivors
  • Medical Research and Clinical Trials

Unmasking the Silent Threat: Groundbreaking St. Jude Research Reveals Genetic Blueprint of Secondary Cancers in Childhood Survivors

Layla Zulfa October 29, 2026
eli-lillys-retatrutide-surges-ahead-in-weight-loss-race-outperforming-novo-nordisks-ozempic-in-landmark-trial
  • Medical Research and Clinical Trials

Eli Lilly’s Retatrutide Surges Ahead in Weight Loss Race, Outperforming Novo Nordisk’s Ozempic in Landmark Trial

Ammar Sabilarrohman October 29, 2026
reclaiming-intimacy-navigating-sexual-health-after-breast-cancer-treatment
  • Patient Advocacy and Support

Reclaiming Intimacy: Navigating Sexual Health After Breast Cancer Treatment

Basiran October 29, 2026
Scientists working with samples in laboratory
  • Patient Advocacy and Support

Breakthroughs in Breast Cancer: Key Insights from the ESMO Annual Congress

Azzam Bilal Chamdy October 29, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.